Ameritas Investment Partners, Inc. Spectrum Pharmaceuticals Inc Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.4 $8,603 - $17,207	-12,291 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $8,348 - $13,680	2,792 Added 29.39%	12,291 $50,000
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $7,985 - $12,217	1,085 Added 12.9%	9,499 $82,000
Q2 2018 Aug 13, 2018	BUY	$14.31 - $21.75 $15,082 - $22,924	1,054 Added 14.32%	8,414 $176,000
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $17,501 - $27,156	1,310 Added 21.65%	7,360 $139,000

Q2 2017 Aug 15, 2017	BUY	N/A	6,050	6,050 $45,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.